Development and validation of a gas chromatography method for determination of ecstasy and amphetamines derivatives in tablets;Desenvolvimento e validação de um método cromatográfico em fase gasosa para análise da 3,4- metilenodioximetanfetamina (ecstasy) e outros derivados anfetamínicos em comprimidos

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 2, 2007, Pages 223-230

  Lasmar, Marcelo Carvalho ^a   Leite, Edna Maria Alvarez ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Faculdade de Farmacia   (Brazil)

Author keywords

Amphetamine derivative; Ecstasy; Flame ionization detection; Gas chromatography determination

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 AMINOBENZOIC ACID; 4 AMINOBENZOYL DIETHYL BARBITURIC ACID; ACETYLSALICYLIC ACID; ADRENALIN; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; CAFFEINE; COCAINE; DIETHYL BARBITURIC ACID; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; UNCLASSIFIED DRUG;

ANALYTICAL RESEARCH; ARTICLE; BRAZIL; GAS CHROMATOGRAPHY; METHODOLOGY; VALIDATION PROCESS;

EID: 34548364040     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-93322007000200008     Document Type: Article

References (23)

1. BURGESS, C.; O'DONOHOE, A.; GILL, M. Agony and ecstasy: a review of MDMA effects and toxicity. Eur. Psychi., v.15, p. 287-294, 2000.
2. CARUSO, M.; JESUS, D. Anova era do ecstasy. Revista Isto É, São Paulo, no1853, p. 62-65. (Caderno Comportamento).
3. CHASIN, A.M.; CHASIN, M.; SALVADOR, M. C. Validação de métodos cromatográficos em análises toxicológicas. Rev. Farm. Bioquim. Univ. S. Paulo, v.30, n.2, p. 49-53, 2004.
4. CHASIN, A.M.; NASCIMENTO, E. S.; NETO, L. M. R.; SIQUEIRA, M. E. P. B.; ANDRAUS, M. H.; SALVADOR, M. C.; FERNÍCOLA, N. A.G.; GORNI, R.; SALCEDO, S. Validação de métodos em análises toxicológicas: uma abordagem geral. Rev. Bras. Toxicol., v.11, n.1, p.1-6, 1998.
5. COLE, J.C.; SUMNALL, H. R. The pre-clinical behavioral pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci. Biobeh. Rev., v.27, n. 3,p.199-217, 2003.
6. COSTA, J. L.; CHASIN, A. A.M. Determination of MDMA, MDEAA and MDA in urine by high performance liquid chromatography with fluorescence detection. J. Chromatog, B, v.811, p. 41-45, 2004.
7. Instituto Nacional de Metrologia, Normalização e Qualidade Industrial - INMETRO. Orientações sobre validação de métodos de ensaios químicos, DOQ-CGCRE-008, 2003.
8. International Union of Pure and Applied Chemistry - IUPAC. Analytical, applied, clinical, inorganic and physical chemistry division. Interdivision working party for harmonization of quality assurance schemes for analytical laboratories. Harmonized guidelines for single laboratory validation of method of analysis. PureAppl. Chem., v.74, n.5, p. 835-855, 2002.
9. LAPACHINSKE, S. F. Quantificação de amostras de MDMA por cromatografia emfase gasosa (CG/NPD). São Paulo. 2004. 93p. [Dissertação de Mestrado. Faculdade de Ciências Farmacêuticas. Universidade de São Paulo].
10. MAURER, H. H.; BICKEBOELLER-FRIEDRICH, J.; KRAEMER, T.; PETERS F.T. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). Toxicol. Lett., v. 112 -113, p.133-142, 2000.
11. MITREVSKI, B.; ZDRAVKOVSKI, Z. Rapid and simple method for direct determination of several amphetamines in seized tablets by GC-FID. Forensic Sci. Int., v. 152, n.2-3, p. 199-203, 2005.
12. MONKEN, M.H. PF apreende 31 mil pílulas de ecstasy. Folha de São Paulo, São Paulo,16 abr., p. C1, 2005. (Caderno Folha Cotidiano).
13. PARROTT, A.C. Chronic tolerance to recreational MDMA (3,4- methylenedioxymethamphetamine) or Ecstasy. J. Psychopharmacol, v 19, n.1, p. 71-83, 2005
14. PARROTT, A.C. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacol, v. 173, n. 3-4, p. 234-241, 2004.
15. RIBANI, M.; BOTTOLI, C. B. G.; COLLINS, C. H.; JARDIN, I.C.S.F.; MELO, L. F. C.; Validação em métodos cromatográficos e eletroforéticos. Quim. Nova, v. 27, n.5, p.771-180, 2004.
16. SARDINHA, L.S.; GARCIA, A.L. Um estudo sobre a psicodinâmica do usuário de ecstasy. Psicologia: Teoria e Prática, v. 2, n.2, p.70-87, 2000.
17. SCHIFANO, F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology, v. 173, n.3-4, p. 242-248, 2004.
18. SOARES, M. E.; CARVALHO, F.; BASTOS, M. L. Determination of amphetamine and its metabolite p-hydroxyamphetamine in rat urine by reversed-phase high-performance liquid chromatography after dabsyl derivatization. Biomed. Chromatog., v. 15, n.7, p.452-456, 2001.
19. SOARES, M. E.; CARVALHO, M.; CARMO, H.; REMIAO, F.; CARVALHO, F.; BASTOS, M. L. Simultaneous determination of amphetamine derivates in human urine after SPE extraction and HPLC-UV analysis. Biomed. Chromatog., v. 18, n.2, p. 125-131, 2004.
20. TAGLIARO, F.; VALENTINI, R.; MANETTO, G.; CRIVELLENTE, F.; CARLI, G.; MARIGO, M. Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licence. Forensic Sci. Int., v.107, n.1-3, p.121-128, 2000.
21. TALWAR, D.; WATSON, I. D.; STEWART, M. J. Routine analysis of amphetamine class drugs as their naphthaquinone derivatives in human urine by high-performance liquid chromatography. J. Chromatog., B, v. 735, n.2, p. 229-241, 1999.
22. WOOD M, LALOUP M, RAMIREZ FERNANDEZ MDEAL M, JENKINS KM, YOUNG MS, RAMAEKERS JG, DE BOECK G, SAMYN N. Quantitative analysis of multiple illicit drugs in preserved oral fluid bysolid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci. Int., v. 150, n.2-3, p.227-238, 2005.
23. WOOD M, DE BOECK G, SAMYN N, MORRIS M, COOPER DP, MAES RA, DE BRUIJN EA. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS. J. Anal. Toxicol., v. 27, n.2, p.78-87, 2003.